We have previously reported a bioassay for human plasma ACTH based upon trypsin dispersed guinea-pig adrenal cells which was sensitive to 100 ng/L ACTH in unextracted human plasma when measured against human pituitary ACTH (1-39) standard 74/555. We now present a bioassay of increased sensitivity (12 ng/L) which incorporates three major changes. The trypsin/trypsin inhibitor step in the cell dispersion protocol has been replaced with collagenase, donor calf serum (3%) has been incorporated into the standard curve and ACTH has been extracted from human plasma and dilutions of standard hormone by a sephacryl bound monoclonal antibody (2A3) directed towards the 25-39 sequence. The extracted standard curve has a detection limit of 6 ng/L and the cells can tolerate up to 50% plasma equivalent concentration. Thus, the improved assay has a detection limit of 12 ng/L ACTH in plasma. The assay can now measure bioactive plasma ACTH levels reliably in the normal range.
SUMMARY. We have previously reported a bioassay for human plasma ACTH based upon trypsin dispersed guinea-pig adrenal cells which was sensitive to 100 ng/L ACTH in unextracted human plasma when measured against human pituitary ACTH (1-39) standard 74/555. We now present a bioassay of increased sensitivity (12 ng/L) which incorporates three major changes. The trypsin/trypsin inhibitor step in the cell dispersion protocol has been replaced with collagenase, donor calf serum (3%) has been incorporated into the standard curve and ACTH has been extracted from human plasma and dilutions of standard hormone by a sephacryl bound monoclonal antibody (2A3) directed towards the 25-39 sequence. The extracted standard curve has a detection limit of 6 ng/L and the cells can tolerate up to 50% plasma equivalent concentration. Thus, the improved assay has a detection limit of 12 ng/L ACTH in plasma. The assay can now measure bioactive plasma ACTH levels reliably in the normal range.
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Bioassays rely upon a functional effect and give information about the biological potency of the molecule, whereas immunoassays rely upon the detection of an antigenic site and give information about the concentration of that structure.
It is now clear that some estimations of hormone concentrations in human plasma by immunoassay are not appropriate to the clinical condition! and there has been renewed interest in bioassay systems. The role of modern bioassays in clinical endocrinology has been reviewed recently.'
Due to the absence of a technically simple bioassay system capable of reliably measuring low levels of bioactive ACTH in human plasma, there is little data in the literature comparing bioactive and immunoactive ACTH measurements. However, these measurements are dissociated in ectopic ACTH syndrome;' possibly due to the secretion ofbioinactive molecules which may be recognised by certain antibodies employed in ACTH immunoassays.
The purpose of this work was to improve the sensitivity of our original bioassay for human plasma ACTH to allow measurement of bioactive ACTH levels in the normal range.
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Our original assay, based upon ACTH stimulated cortisol production from dispersed guineapig adrenal cells, was capable of specifically, accurately and precisely detecting ACTH down to 100 ng/L" in unextracted human plasma as measured against human pituitary ACTH (1-39) standard 74/555.4.5 In view of the evidence that ACTH-stimulated steroidogenesis involves a natural proteolytic event which can be inhibited by trypsin inhibitors," we have investigated the effect of replacing the trypsin/trypsin inhibitor step in the cell dispersion protocol'v' by collagenase. We have also examined the effect of donor calf serum (2-4%) on the responsiveness of the cells to ACTH, with a view to making the matrix of the standard curve similar to that present in test samples. In order to measure low levels of ACTH, we have attempted to extract bioactive ACTH from plasma using an immunoextraction procedure. This employs a "Lambert et a/.,4 in fact, quote a detection limit of 50ng/L ACTH in unextracted human plasma as measured against human pituitary ACTH (1-39) standard 74/555. However this value was based on 11'61lg ACfH per ampoule as indicated at that time by National Institute of Biological Standards and Control (NIBSC). NIBSC have revised this estimate and now inform users that the ACfH content of standard 74/555 is 25Ilg/ampoule. monoclonal antibody (2A3) directed against the 25-39 sequence, the 1-24 region being responsible for biological activity.?" This antibody is linked to an inert covalently-linked dextran gel, Sephacryl." Some of these results have been presented in a preliminary form elsewhere. 10 .II
MATERIALS AND METHODS

Preparation of dispersed cells
The methodology described has been reported in detail earlier.v' Briefly, adrenal glands from a single male Dunkin-Hartley guineapig (body weight 500-750 g) were removed immediately after cervical dislocation. The glands were chopped into I mm cubes using a McIllwain tissue chopper and washed in cold oxygenated Eagles minimum essential medium (EM EM, Flow Labs, Irvine, Scotland). The fragments were discontinuously dispersed (2 x 10min, 2 x 30 min) using collagenase (2 mgjml, Cooper Biomedical) in EMEM. The cell suspensions arising from dispersions 2-4 were pooled, filtered through 100 J.Lm pore nylon mesh (Simon Engineering, Stockport, UK) and washed twice by centrifugation at 100g into incubation medium (medium A, EMEM containing 8 mM CaCI 2 , 0·5% bovine serum albumin) containing 2 mMascorbate. Following a preincubation of 2 h at 37°C in a humidified atmosphere of 100% O 2 , the cells were resuspended into fresh incubation medium containing 4mM ascorbate. Using the trypan blue exclusion method, the cell concentration was adjusted to give a final concentration of 0·75 x 10 6cells/mL.
Construction of the standard curve
Graded doses of ACTH 1-39 (NIBSC code 74/ 555; 25 J.Lg/ampoule) were added into medium A (incubation medium alone), or medium B (incubation medium with donor calf serum DCS) to produce a range of final concentrations of 2-40 ng/L ACTH.
Preparation of quality control plasma samples
A pool of HI V-screened human plasma was heat treated at 55°C to inactivate complement. A 5% slurry of Sephacryl bound antibody 2A3 was washed in phosphate buffered saline (PBS, Flow Labs) to remove dissociated antibody. The supernatant was replaced with an equivalent volume of treated plasma and shaken for 2 h at room temperature. Following centrifugation the 'ACTH-free' plasma was removed by aspiration. ACTH 1-39 was added into the plasma to give quality control samples (QCs) of concentrations 500, 200, 100, 80ng/L ACTH. These were dispensed into 200 J.LL aliquots in plastic tubes, snap frozen and stored at -70°C.
Collection of dexamethasone-suppressed plasma
Eight normal volunteers were given dexamethasone (1. 5 mg) at 2300 hand O' 5 mg at 0900 h the following morning. Blood was collected at 1430 h. The plasma was collected into plastic tubes and stored at -20°C. The cortisol concentration of each plasma was < 60 nmol/L.
Sample preparation for bioassay
During the cell preincubation period, test and QC samples were diluted in incubation medium to produce a minimum of two assay dilutions (>1 in 10).
Unextracted bioassay methodology
Twenty-five microlitre aliquots of preincubated cells were placed in a vented 96 well micro titre plate (Northumbria Biologicals Limited). Twenty-five rnicrolitres of each dilution of standard ACTH, test or QC plasma were added. The plate was incubated for 90min at 37°C in 100%°2 , Finally the plate was cooled on ice prior to removal of duplicate 10J.LL samples for determination of cortisol by radioimmunoassay.
Extracted bioassay methodology
The antibody for immunoextraction 2A3 is coupled to Sephacryl" and is present in excess. A 2·5% slurry of Sephacryl-bound antibody 2A3 was washed in PBS. Two-hundred microlitre aliquots were centrifuged and the supernatant volume replaced with standard ACTH, or plasma sample or QC (200 J.LL). The incubates were shaken for 2 h at room temperature, centrifuged at 100g, and the supernatant removed. The extracts were diluted in incubation medium containing 3% DCS to give a volume equivalent to the initial volume of sample (100% plasma equivalent). The sample extracts were further diluted producing a range of plasma equivalent concentrations from 100% to 2%. Twenty-five microlitres of each dilution of extract were added to 25 J.LL of adrenal cells such that the final plasma equivalent concentration ranged from 50% to I %. The plate was incubated for 90 min at 37°C in 100% O 2 , Duplicate 10J.LL samples were again taken for estimation of cortisol by standard radioimmunoassay. BOOO 
RESULTS
Between assay CV was < 19%. Collagenase dispersed cells could tolerate up to 10% plasma without loss of parallelism. Assaying at a lO-fold dilution, the limit of detection of ACTH in unextracted plasma was 30 ngjL. Recovery of human pituitary ACTH (1-39) spiked into dexamethasone-suppressed plasma at a concentration of 500 or 200 ng{L was 133 ± 15% (n = 10) and 152 ± 12% (n = 10), respectively. The CV of quality control (QC) plasma and of patients' samples was < 8% (within batch) and < 16% (between batch).
Effect of donor calf serum
The effect of incorporation of donor calf serum (DCS 2-4%) on cortisol output from collagenase dispersed cells was studied. The cortisol response to ACTH (6-20 ng{L) was significantly higher in the presence of 3% DCS than in the presence of 2% (P < 0'05). No further increase in cortisol secretion was observed using 4% DCS. In the presence of 3% DCS the limit of detection of the standard curve and of ACTH in plasma was unchanged (3 ngjL and 30 ng/L, respectively). However, the dose response curve in the presence of 3% DCS was shifted to the left relative to the standard curve in the absence of DCS (Fig. I) .
The standard curve was also more reproducible. The within assay CV was < 8% at all doses and between assay CV was < 10%. Recovery of ACTH from QC samples containing 500 and 200 ng{L was 93 ± 14% and 106 ± 9%, respectively. Serial dilutions (10-100 fold) of patients' and quality control plasmas were found to be parallel with dilution (Table I ).
Immunoextraction of ACm
The effect ofSephacryl alone (5%) on the ACTH dose response curve was examined. The presence of Sephacryl beads had no significant effect (P > 0,05) on the responsiveness of the cells to ACTH (0-40 ngjL). A series of control experiments were performed using a QC plasma sample containing 500 ng{L ACTH ( Table 2 ). The concentration of ACTH in unextracted plasma was measured by bioassay (512 ± 52 ng{L) and immunoradiometric assay (608 ± 27 ng{L).
Treatment of the plasma with Sephacryl (5%) alone resulted in < 2% non-specific binding to the beads and> 90% of the bioactive ACTH was present in the supernatant. Extraction of the plasma with Sephacryl-2A3 (5%) resulted in a recovery of 352 ng{L, i.e. -70% of the bioactive material, when measured against an unextracted standard curve. However, in the supernatant no ACTH was detectable by bioassay. Finally, the ACTH immunoradiometric assay Antibodies 2A3 and IAI2 were coupled to Sephacryl as described previously." The ACTH immunoradiometric assay was performed exactly as described by White et al. 9 Statistical analysis of results Duplicate cultures were set up and duplicate samples were.taken from each well. Experiments were repeated three times. Levels of significance were determined by Student's (-test. 
recovery of bioactive ACTH using a second monoclonal antibody IA-l2, which is directed to the 11-17 sequence of the ACTH molecule, was studied. Treatment of the plasma with Sephacryl-IAI2 effectively immunosuppressed the ACTH bioactivity ( Table 2) . Incorporation of Sephacryl bound to antibody 2A3 (0-10% slurry) resulted in a concentration dependent shift in the dose response curve to the right, indicating a matrix effect (data not shown). This matrix effect could be reduced by using a 2·5% slurry of Sephacryl-2A3 without adversely affecting the recovery. Figure 2 shows a standard curve in which each dilution of standard ACTH has been extracted with a 2·5% slurry of Sephacryl-2A3. Although extraction decreased the sensitivity of the standard curve from 3 ng/L to 6 ng/L, the collagenase dispersed cells were found to tolerate up to 50% plasma equivalent concentration without loss of parallelism (Table  1) , a five-fold improvement over a 10% plasma tolerance by the unextracted assay. Thus, this assay has a detection limit of 12ng/L, Using this system, extraction and assay of a quality control plasma containing 100ng/L has resulted in a recovery of 108 ± 16ng/L (n = 10 experiments) when measured against an extracted standard curve. Preliminary data also indicate that ACTH levels in normal subjects are detectable (24 ± 3 ng/L, n = 5, at 0700 h). However ACTH levels in dexamethasone suppressed subjects remain undetectable in this system « 12ng/L, n = 8).
DISCUSSION
Using modifications to the existing bioassay described by Lambert et al!·5 we have increased the sensitivity to 12ng/L in extracted human plasma. These modifications included the replacement of the trypsin/trypsin inhibitor step in the cell dispersion protocol by collagenase. This led to an increase in sensitivity from 100ng/ L to 75 ng/L plasma, i.e. 3 ng/L detected at a 1 in • In these cases, immunoradiometric assay of the extract was not possible as antibodies 2A3 and 1A12 are the pair of antibodies used in the IRMA. 1000 3000 degradation by trypsin-like enzymes. 12 The ACTH bound to Sephacryl-2A3 may be presented to adrenal cells without separation from its solid phase support because the region 4-10 is available for biological activation" and the region 15-18 is available for binding of the ACTH molecule to its receptor." ACTH bound to Sephacryl-2A3 is able to stimulate secretion from guineapig adrenal cells in a dose dependent manner, whereas Sephacryl alone has no effect on the ACTH dose/response curve. Extraction of plasma ACTH with Sephacryl-2A3 resulted in a recovery of approximately 70% of the bioactive material, when measured against an unextracted standard curve. This low recovery was, in part, due to a matrix effect. However, another possible explanation is the large size of the Sephacryl beads (40-100j.l) relative to the adrenal fasciculata cell (21 /l)Y This may result in some of the antibody bound ACTH being unavailable for binding to the adrenal fasciculata cell. Treatment of plasma with antibody lA-12, an antibody directed to the 11-17 sequence which is close to the ACTH binding site, effectively immunosuppressed the ACTH bioactivity. The ACTH standard curve, when extracted with 2·5% Sephacryl-2A3, tolerated up to 50% plasma equivalent concentration without loss of parallelism and was always sensitive to 6 ng/L ACTH (P < 0'001). Therefore, the improved assay has a formal detection limit of 12 ng/L ACTH in plasma.
In summary, the simple immunoextraction procedure described in this paper has increased the sensitivity of the ACTH bioassay such that measurement of bioactive plasma ACTH levels in the normal range is now feasible. 25 dilution of plasma, the maximum the trypsinised cells could tolerate without loss of parallelism. However, collagenase dispersed cells were able to tolerate up to 10% human plasma leading to a further increase in sensitivity to 30 ng/L plasma ACTH. Finally, the incorporation of 3% donor calf serum shifted the dose response curve to the left resulting in an improvement in the precision of the system, although not sensitivity. In addition, the presence of serum improved the accuracy of the bioassay by reducing the matrix effect. This is illustrated by the recovery of ACTH from QC (200 ng/L) falling from 152 ± 12% (no serum in the standard curve) to 106 ± 9% (3% DCS).
The major modification introduced for the ACTH bioassay involves the use ofa monoclonal antibody 2A3 to extract ACTH from plasma thereby removing interference by undetermined plasma factors. This antibody is of low affinity, is directed to the 25-39 sequence of ACTH and can be linked to an inert covalently linked dextran gel. We have reported previously that cortisol production by dispersed guineapig adrenal cells is specific to ACTH and its fragments.' The use of antibody 2A3 therefore ensures that any form of ACTH containing the 25-39 sequence will be made available for bioassay. In the native molecule the terminal amino acid sequence 26-39 is thought to protect the basic core 15-18 against 
